We are looking for 2 to 17 years of age to join a Crohn’s disease (CD) clinical research to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or moderately to severely active IBD (including associated symptoms such as diarrhea with blood and pus, kidney stones, bloody stool, weight loss and/or joint pain), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Enrollment is limited, so please respond now.
